BioConsortia
DAVIS, CA · Biotechnology, Other · 50 employees
BioConsortia, Inc. is revolutionizing agriculture with cutting-edge microbial solutions that boost plant health, increase yields, and promote sustainability. As leaders in gene editing and directed selection of microbes, BioConsortia harnesses the power of robust, spore-forming bacteria to develop innovative seed treatments and foliar products. The company’s proprietary Advanced Microbial Selectio
Funding history
- Seed — $15.0M — Aug 2025
- Funding Round — $15.0M — Apr 2024
- Venture - Series Unknown — $15.0M — Apr 2023
- Venture - Series Unknown — $8.0M — Mar 2019
- Venture - Series Unknown — Undisclosed — Mar 2019
Recent signals
- Jun 01, 2026: BioConsortia Appoints Dr. Damian Curtis as Senior Vice President of Research & Development
- Aug 03, 2025: Raised $15.0M in Seed
- Apr 01, 2024: Raised $15.0M in Funding Round
- Apr 20, 2023: Raised $15.0M in Venture - Series Unknown
- Mar 27, 2019: Raised $8.0M in Venture - Series Unknown
- Mar 27, 2019: Raised Undisclosed in Venture - Series Unknown
- Mar 13, 2018: Raised $10.0M in Venture - Series Unknown
- Oct 27, 2016: Raised $8.0M in Venture - Series Unknown
See plans & pricing → Track BioConsortia’s funding, hiring, and signals — with verified contacts — on Fundz.